PMPS Article (Samedan): February 2018

Download PDF

Demonstrating Bioequivalence of Orally Inhaled Products

Safe and cost-effective treatments for respiratory diseases are facing a growing demand. The demonstration of bioequivalence within locally acting drugs, such as orally inhaled products, could prove particularly challenging.